Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Vano"'
Autor:
Jordi Frigola, Calvet C, Redondo J, Antoni Torrens, Josep Mas, José A. Castrillo, Santiago García-Granda, David Vano, Berrocal Jm, Salgado L
Publikováno v:
Journal of Medicinal Chemistry. 37:4195-4210
A series of 7-(2,3-disubstituted-1-azetidinyl)-1,4-dihydro-6-fluoro-4- oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids, with varied substituents at the 1-, 5-, and 8-positions, was prepared to study the effects on potency and physicochemical
Autor:
Maria Carme Calvet, Leonardo Salgado, Júlia Alegre, Daniel Zamanillo, José Miguel Vela, David Vano, Maria Teresa Serafini, Enric Hernandez, Helmut Buschmann, Rosalia Pascual, Alberto Dordal, Sandra Yeste, Núria Cano, Marisol Escriche, Jordi Corbera, Daniel Martínez, Raquel Pérez, Mónica Carro, Jörg Holenz, Francesc Andreu
Publikováno v:
ChemMedChem. 1(1)
Based on a medicinal-chemistry-guided approach, three novel series of druglike cycloalkyl-annelated pyrazoles were synthesized and display high affinity (pKi>8) for the sigma1 receptor. Structure-affinity relationships were established, and the diffe
Autor:
Edmundo Ortega, Jordi Frigola, David Vano, Santiago García-Granda, Angels Gomez-Gomar, Antoni Torrens
Publikováno v:
Journal of medicinal chemistry. 38(7)
A series of stereochemically pure 7-(3-amino-2-methyl-1-azetidinyl)-1,4- dihydro-6-fluoro-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids, with varied substituents at the 1-, 5-, and 8-positions, was prepared to determine the effects of chi
Autor:
Marchena Yglesias, Pablo Javier, Rodríguez, José Antonio Nieto, García, Gregorio Arranz, Sanchís, David Vaño, Muños, Natividad Sánchez-Manjavacas, Nuñez, José Francisco Dimas
Publikováno v:
In European Journal of Internal Medicine 2006 17(3):209-210
Publikováno v:
In European Journal of Internal Medicine 2006 17(1):72-72
Publikováno v:
In European Journal of Internal Medicine 2005 16(1):64-64